Xcout IntelSign inSubscribe

CollPlant Biotechnologies Ltd.

CLGNBiotechnologyRehovot, Israel

CollPlant Biotechnologies Ltd. is a biotechnology company headquartered in Rehovot, Israel. The company focuses on regenerative medicine and reports its financial results in U.S. dollars.

Subscribe to see CollPlant Biotechnologies Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

CollPlant Biotechnologies Ltd. at a glance

CollPlant Biotechnologies Ltd. is a biotechnology company headquartered in Rehovot, Israel, founded in 1981. It is publicly listed (CLGN) with a market capitalisation of $4.5M. Xcout tracks 31 named people at CollPlant Biotechnologies Ltd., including Yehiel Tal (CEO & Chairman).

Industry
Biotechnology
Headquarters
Rehovot, Israel
Market cap
$4.5M
Employees
39
Ticker
CLGN
Founded
1981

CollPlant Biotechnologies Ltd. leadership

  • Yehiel TalCEO & Chairman
  • Eran RotemDeputy Chief Executive Officer & Chief Financial Officer
  • Hadas Dreiher HorowitzVice President of Human Resources
  • Oded ShoseyovFounder & Chief Scientist
  • Prof. Oded ShoseyovFounder and Chief Scientist
  • Oren FahimipoorVice President of Operations

25 more named people on record for CollPlant Biotechnologies Ltd., with roles, board committees and tenure — see the full roster →

CollPlant Biotechnologies Ltd. competitors

A few of CollPlant Biotechnologies Ltd.'s closest competitors — see the full list of competitors and alternatives →

Organogenesis Holdings Inc.ORGO · BiotechCanton, United States
69% matchPublic

Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital cells, growth factors, and ECM proteins found in natural tissue. Apligraf is a bioengineered living cell therapy that releases a range of healing cytokines and growth factors, while Dermagraft is another bioengineered solution that generates human collagen, ECM, proteins, and cytokines. NuShield provides a wound covering incorporating both amnion and chorion membranes to maintain a spongy intermediate layer. PuraPly acts as an antimicrobial barrier, allowing for flexibility and effective fluid drainage. For the surgical and sports medicine sectors, the company provides products such as NuCel, a dehydrated placental tissue designed for surgical application to promote natural tissue regeneration. ReNu is a cryopreserved suspension aimed at aiding soft tissue recovery. Additionally, FiberOS and OCMP serve as bone void fillers, primarily utilized in orthopedic and neurosurgical procedures. Looking ahead, Organogenesis's product pipeline features PuraPly XT and PuraPly MZ, which are being developed for treating chronic, acute, and open wounds. PuraForce is a bioengineered porcine collagen surgical matrix intended for soft tissue reinforcement. TransCyte, another bioengineered tissue, is in development for addressing partial thickness burns. Organogenesis distributes its offerings to a diverse client base, including hospitals, specialized wound care centers, government institutions, ambulatory surgical centers, and physician offices, leveraging both its direct sales team and independent agencies. Established in 1985, the company maintains its headquarters in Canton, Massachusetts.

Market cap$162.8M
Employees869
Organogenesis Holdings Inc. competitors & alternatives →

Get CollPlant Biotechnologies Ltd.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

CollPlant Biotechnologies Ltd. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on CollPlant Biotechnologies Ltd. in Xcout Intel

  • 31 named people with titles, LinkedIn and board committees
  • 8 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →